| Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells JL Simonsen, C Rosada, N Serakinci, J Justesen, K Stenderup, ... Nature biotechnology 20 (6), 592-596, 2002 | 981 | 2002 |
| Adult human mesenchymal stem cell as a target for neoplastic transformation N Serakinci, P Guldberg, JS Burns, B Abdallah, H Schrĝdder, T Jensen, ... Oncogene 23 (29), 5095-5098, 2004 | 494 | 2004 |
| The ocean sampling day consortium A Kopf, M Bicak, R Kottmann, J Schnetzer, I Kostadinov, K Lehmann, ... Gigascience 4, 1-5, 2015 | 210 | 2015 |
| Primary culture RI Freshney Culture of animal cells: a manual of basic technique, 2005 | 115* | 2005 |
| Therapeutic potential of adult stem cells N Serakinci, WN Keith European journal of cancer 42 (9), 1243-1246, 2006 | 105 | 2006 |
| A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT K Lafferty-Whyte, CJ Cairney, MB Will, N Serakinci, MG Daidone, ... Oncogene 28 (43), 3765-3774, 2009 | 98 | 2009 |
| Telomere stability and telomerase in mesenchymal stem cells N Serakinci, J Graakjaer, S Kolvraa Biochimie 90 (1), 33-40, 2008 | 93 | 2008 |
| Mesenchymal stem cells, cancer challenges and new directions N Serakinci, U Fahrioglu, R Christensen European Journal of Cancer 50 (8), 1522-1530, 2014 | 73 | 2014 |
| Ectopically hTERT expressing adult human mesenchymal stem cells are less radiosensitive than their telomerase negative counterpart N Serakinci, R Christensen, J Graakjaer, CJ Cairney, WN Keith, J Alsner, ... Experimental cell research 313 (5), 1056-1067, 2007 | 70 | 2007 |
| Telomerase promoter reprogramming and interaction with general transcription factors in the human mesenchymal stem cell N Serakinci, SF Hoare, M Kassem, SP Atkinson, WN Keith Future Medicine Ltd 1 (1), 125-131, 2006 | 69 | 2006 |
| The role of human papillomaviruses in cancer progression P Tulay, N Serakinci J Cancer Metastasis Treat 2 (6), 201, 2016 | 68 | 2016 |
| Role of melatonin in the treatment of COVID-19; as an adjuvant through cluster differentiation 147 (CD147) AO Sehirli, S Sayiner, N Serakinci Molecular biology reports 47 (10), 8229-8233, 2020 | 58 | 2020 |
| Association of leptin receptor gene Q223R polymorphism on lipid profiles in comparison study between obese and non-obese subjects E Becer, G Mehmetçik, H Bareke, N Serakıncı Gene 529 (1), 16-20, 2013 | 50 | 2013 |
| A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria WN Keith, T Vulliamy, J Zhao, C Ar, C Erzik, A Bilsland, B Ulku, A Marrone, ... BMC Hematology 4, 1-8, 2004 | 47 | 2004 |
| Transformation of human mesenchymal stem cells in radiation carcinogenesis: long-term effect of ionizing radiation R Christensen, J Alsner, F Brandt Sorensen, F Dagnaes-Hansen, ... Future Medicine Ltd 3 (6), 849-861, 2008 | 46 | 2008 |
| Mesenchymal stem cells as therapeutic delivery vehicles targeting tumor stroma N Serakinci, R Christensen, U Fahrioglu, FB Sorensen, ... Cancer Biotherapy and Radiopharmaceuticals 26 (6), 767-773, 2011 | 45 | 2011 |
| Detection and sizing of telomeric repeat DNA in situ N Serakinci, J Koch Nature Biotechnology 17 (2), 200-201, 1999 | 37 | 1999 |
| Telomere dynamics in human mesenchymal stem cells after exposure to acute oxidative stress M Harbo, S Koelvraa, N Serakinci, L Bendix DNA repair 11 (9), 774-779, 2012 | 35 | 2012 |
| Impact of circadian disruption on health; SIRT1 and Telomeres M Osum, N Serakinci DNA repair 96, 102993, 2020 | 29 | 2020 |
| Mesenchymal stem cells with high telomerase expression do not actively restore their chromosome arm specific telomere length pattern after exposure to ionizing radiation J Graakjaer, R Christensen, S Kolvraa, N Serakinci BMC molecular biology 8, 1-11, 2007 | 28 | 2007 |
Moustapha KassemUniversity Hospital of OdenseVerified email at health.sdu.dk
